Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Carriers01:24

Electron Carriers

92.1K
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons.
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
92.1K
Carrier Transport01:21

Carrier Transport

994
The generation of electrical current in semiconductors is fundamentally driven by two mechanisms: drift and diffusion. These processes are essential for the functionality and performance of semiconductor-based devices.
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
994
The ADP/ATP Carrier Protein01:42

The ADP/ATP Carrier Protein

4.3K
ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
4.3K
Carrier Generation and Recombination01:22

Carrier Generation and Recombination

1.3K
Carrier generation is the process by which electron-hole pairs (EHPs) are created within the semiconductor. In direct-bandgap semiconductors, such as gallium arsenide (GaAs), this occurs efficiently when energy absorption prompts valence electrons to leap into the conduction band, leaving behind holes.
This process is given by the generation rate G and is efficient due to the conservation of momentum between the valence band maximum and conduction band minimum.
Indirect generation involves an...
1.3K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.3K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.3K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

6.3K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adolescent obesity and risk of serious chronic morbidity and mortality in young adulthood: a systematic review of cohorts from national registries.

Cardiovascular diabetology·2026
Same author

Adolescent Blood Pressure and Cardiovascular Disease Before Age 50 Years.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

A novel spliceosomopathy caused by de novo SF3B3 variants.

Genome medicine·2026
Same author

Delayed puberty and early-onset type 2 diabetes risk: a nationwide cohort study of male adolescents in Israel.

The Lancet. Child & adolescent health·2026
Same author

Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review.

Diabetes, obesity & metabolism·2026
Same author

Bone Turnover Markers (CTX and P1NP) Following Low-Carbohydrate and Mediterranean Diet Interventions in Adolescents and Young Adults with Type 1 Diabetes.

Nutrients·2025

Related Experiment Video

Updated: Feb 11, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.6K

[FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?]

Shai Elizur1,2, Michal Berkenstadt3,2, Liat Ries-Levavi4,2

  • 1IVF Unit, Sheba Medical Center, Tel Hashomer.

Harefuah
|April 25, 2018
PubMed
Summary

Fragile X Syndrome (FXS) involves CGG repeat expansions in the FMR1 gene. Premutation carriers face risks for FXPOI and FXTAS, with ongoing research into molecular pathogenesis.

More Related Videos

Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

10.2K
Transcription Start Site Mapping Using Super-low Input Carrier-CAGE
06:59

Transcription Start Site Mapping Using Super-low Input Carrier-CAGE

Published on: June 26, 2019

12.5K

Related Experiment Videos

Last Updated: Feb 11, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.6K
Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

10.2K
Transcription Start Site Mapping Using Super-low Input Carrier-CAGE
06:59

Transcription Start Site Mapping Using Super-low Input Carrier-CAGE

Published on: June 26, 2019

12.5K

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Fragile X Syndrome (FXS) is caused by CGG trinucleotide repeat expansions in the FMR1 gene.
  • Full mutations (>200 repeats) lead to FMR1 gene silencing and absence of FMRP, causing FXS.
  • Premutations (55-199 repeats) increase risk for FXPOI in females and FXTAS in males.

Purpose of the Study:

  • To investigate the molecular pathogenesis of FXPOI and FXTAS.
  • To explore the role of increased FMR1 transcript levels in premutation carriers.
  • To highlight the multidisciplinary approach for early detection and care of FMR1 premutation carriers.

Main Methods:

  • Analysis of CGG repeat expansions in the FMR1 gene.
  • Assessment of FMR1 transcript levels in premutation carriers.
  • Multidisciplinary clinical evaluation and consultation.

Main Results:

  • Premutation carriers exhibit increased FMR1 transcript levels.
  • Two models, toxic RNA gain-of-function and RAN translation, are proposed for FXPOI and FXTAS.
  • A multidisciplinary center provides comprehensive care for FMR1 premutation carriers and families.

Conclusions:

  • Increased FMR1 transcript levels may underlie FXPOI and FXTAS pathogenesis.
  • Understanding molecular mechanisms is crucial for managing FXS and related disorders.
  • Early detection and multidisciplinary care are essential for FMR1 premutation carriers.